Background: To determine the efficacy of magnetic stimulation (MS) in female patients with stress urinary incontinence (SUI) by performing a meta-analysis on peer-reviewed randomized controlled trails (RCTs).
Introduction
Stress urinary incontinence (SUI), a chronic and debilitating condition, is defined as involuntary loss of urine on physical exertion, sneezing or coughing. [1] As a greater proportion of women survive into later life, there are more older women with the SUI than in previous years. The burden of SUI is increasingly high in hospitalizations, home nursing, economics, and cost of pads, diapers, and bedding. [2] SUI symptoms are negatively associated with not only sexual function but mental health. [3, 4] AUA/SUFU guidelines recommend pelvic floor muscle training (PFMT) as the first-line treatment for SUI. [5] PFMT, more commonly known as Kegel exercises, should be performed several times a day and need to be conducted consistently over time for benefit to be sustained (e.g. 2-6 s/time, 3-8 groups/day, ≥8weeks). Low compliance often led to poor results. As for surgical correction of SUI, midurethral synthetic slings (MUS) was regarded as an optimal choice with objective cure rates ranging between 83.9% and 100%. [6] Nevertheless, complications including pain, mesh erosion and extrusion, and wound infections usually made quality of life (QoL) worse. [7] Thus, patients with SUI who did not want to undergo surgical treatment were more likely to favor other types of conservative therapies.
Electrical stimulation (ES) was one of popular conservative therapies and was reported to be an effective treatment. However, pain and discomfort caused by percutaneous electrical current limited the use of ES. [8] [9] [10] A few studies reported that magnetic stimulation (MS) was a noninvasive and effective intervention for SUI without obvious side effects, which led to significant improvements in urodynamic variables and a reduction in the frequency of leakage on pad testing. [11] [12] [13] [14] The mechanism of MS was considered as the same as that of ES, which might not only contract the pelvic floor muscles, but simultaneously inhibit the antagonistic reflex mechanism for emptying the bladder. [15, 16] However, other research has reported little efficacy of MS for SUI, and the efficacy is still controversial. [17] [18] [19] We, therefore, conducted a systematic review and meta-analysis of the RCTs to evaluate the use of MS.
Materials and methods

Search strategy
This study was performed according to the Preferred Reporting Items of Systematic Reviews and Meta-Analyses (PRISMA) guidelines. [20] The PubMed, Embase, and Cochrane library were searched for studies published up to July 2018. The electronic search was performed to capture all relevant studies by performing the following search strategy: (urinary incontinence OR stress urinary incontinence OR stress incontinence) AND (magnetic stimulation OR magnetic stimulation therapy OR magnetics OR extracorporeal magnetic innervation OR magnetic therapy OR conservative treatment) AND (clinical trials OR RCT). Furthermore, relevant conference proceedings and literature references of the EAU, IUGA, and ICS up to 2018 were searched manually. The procedure of retrieving and evaluating the papers was conducted independently by 2 authors (XZ and LP), and differences were solved through a discussion. This study does not need IRB approval because the data were obtained from studies freely available on the internet instead of being directly collected from institutions or patients.
Study inclusion criteria
Patients were diagnosed with SUI; Magnetic stimulation or sham therapy were used for SUI patients; Some outcome-reporting parameters were recorded in study; Where there were duplications in congress abstracts or published journals, the data were rechecked to verify equivalence, and the most up-to-date or complete studies were eligible.
Study exclusion criteria
Studies were excluded according to the following criteria: the study type was a letter, review, comment, or case report; there was a lack of a comparative placebo-controlled group and quantitative data; patients were diagnosed with mixed SUI or urgency urinary incontinence and undergoing several different treatments. Selection process was shown in Figure 1 .
Study quality assessment
The quality of the included RCTs was assessed according to the Cochrane Collaboration Reviewers' Handbook [21] by LP and XZ. The quality standards consisted of generation of randomization sequences, allocation concealment, blinding, incomplete outcome data, freedom from selective reporting, and freedom from other biases. The results of assessment were shown in Table 1 .
Outcomes
To evaluate the efficacy of MS, the primary outcomes of interest were considered as urine loss on pad test per day, number of leaks in a 3-day voiding diary, changes in urodynamic parameters, improvement rate, QoL scores, International Consultation on Incontinence Questionnaire (ICIQ) scores and KHQ scores (incontinence impact). UTI, pain, discomfort, new depression, influence on social life and personal relationship were regarded as the secondary endpoints to evaluate safety.
Statistical methods
Review Manager 5.3 (Cochrane Collaboration, Oxford, UK) was used to perform all calculations and data manipulations. Heterogeneity was evaluated by I 2 tests, with significance set at P < 0.05. I 2 values of 25%, 50%, and 75% corresponded to low, medium, and high levels of heterogeneity, respectively. The fixed-effect method was used for studies without significant heterogeneity, and random-effect method was used with I 2 values ≥50%.
Results
Characteristics of the included studies
A total of 330 studies were identified based on a defined search strategy. Around 87 papers were excluded for non-RCTs or nonclinical trials and 26 studies with different base line or different diagnosis or different group settings were also excluded. The reviewers (LP and XZ) independently assessed the complete articles and made their selection in accordance with the eligibility criteria. Finally, 4 studies [22] [23] [24] [25] were eligible for systematic review after critical evaluation. The main characteristics of studies identified were presented in Table 1 .
Synthesis of results
As shown in Figure 2 , compared to the sham stimulation, MS group had a significantly less no. of leaks/3 days (MD = À1.42; 95%CI: À2.42 to À0.59; P = .007) (Fig. 2 A) , less urine loss on pad test (g)/24 h (MD = À4.99; 95%CI: À8.46 to À1.53; P = .005) (Fig. 2B) , higher QoL scores (MD = 0.42; 95%CI: 0.02 to 0.82; P = .009) (Fig. 2C) , and lower ICIQ scores (MD = À 4.60; 95%CI: À5.02 to À4.19; P < .001) (Fig. 2 D) . No publication bias was identified (Fig. 3) .
The improvement rates in Fujishiro et al in MS and sham group were 74% and 32%, respectively. In Lim et al, the improvement rate was 60% in the experimental group compared to 15% in the control group. Studies reported no MS-related adverse effects.
Discussion
To the best of our knowledge, this is the first study to investigate the efficacy of MS in female patients with SUI in short-term follow-up. MS significantly improved the symptoms of SUI, reduced the number of leaks and the average daily loss of urine, with lower ICIQ scores and improved QoL scores. Around 74% and 32%, 60% and 15% of improvement rates in MS and sham group were, respectively, reported in 2 RCTs. [23, 25] Furthermore, a reduction in the number of leaks and urodynamic improvement, including an increase in maximum urethral closure pressure and change in abdominal leak point pressure, were recorded. [23, 26] Gratifyingly, no MS-related side effects were reported. These results suggested that MS of the sacral roots or pelvic floor was useful, effective and safe for the treatment of SUI in the short-term follow-up.
MS is considered to improve PFM strength and endurance through repetitive contractions and exercises. The contraction of the detrusor muscle was inhibited by vigorous voluntary activation of the muscles of the pelvic floor. [15, 27] Sheriff et al [12] studied 7 patients following spinal cord injury with intractable detrusor hyper-reflexia and found a profound reduction in detrusor contraction and significant improvement of urodynamic parameters. In the study of Yokoyama et al, [28] cure rate of SUI after MS therapy was 52.9%, the one-hour urine loss reduced from 7.9 to 1.9 g at 8 weeks. Significant improvement in both U-UDI scores and the Incontinence Impact Questionnaire Short Form total scores were recorded with a cure rate for SUI was 42.1% in study by Lo Tsia-Shu et al [14] Galloway et al [13] reported improvement and cure rates for MS therapy of 66% and 34%, respectively, within 6 months. These studies supported our conclusions and the mechanism of MS, which proved the effectiveness of MS and it a recommending treatment.
However, it should be kept in mind that, according to the included studies, our results were limited to 14 months, and the long-term efficacy was not clear. Ismail et al [19] proposed that there was no significant change in QoL scores and KHQ scores at 3-month follow up. As we know, if SUI could not be completely cured, even though the QoL scores were improved in the short time, long term these outcomes may not be preserved. A 3-year prospective study [29] of outcomes from MS for SUI showed continued benefit of MS for 1 year after therapy but gradually decreased and came close to baseline with high recurrence at the 3rd year. Another study by Hoscan et al [30] reported that the effects of MS did not last for 2 years. The long-term outcomes of this technique remain unclear.
Side effects related to the treatment were rare, which confirmed the safety of MS. Minimal or no adverse events reported in other studies from the USA, [13] Japan, [8, 23] and Turkey, [31] supported that MS was tolerable and caused no anxiety in the majority of patients.
Although different regimes were used to treat SUI, the frequencies used varied between 15 and 50 Hz, and the length of treatment was not identical, clinical results were consistent excellent and unifying in the short-term follow-up. There was uncertainty about the optimum duration of treatment and the extent to which any symptomatic improvement was maintained after treatment was discontinued. The role of maintenance therapy was also unclear. When it comes to clinical decision making, further long-term research should focus on the best MS treatment model before MS is put into clinical practice. By performing an effective communication and a good counseling using useful communication skills, patients can obtain a clear understanding of clinical conditions and the risks and benefits of potential treatment options. [32] A large number of patients had pelvic organ prolapse (POP) associated to SUI. [33] MS could be considered as a conservative and noninvasive treatment for concomitant SUI and de novo SUI. To determine the efficacy of MS for SUI in the presence of POP, a prospective study is needed.
According to the inclusion criteria defined previously, 6 articles [22] [23] [24] [25] 34, 35] initially met the criteria. However, the research of But et al, [35] drawing the same conclusion with our study, was dedicated to urinary incontinence including stress, urgency, and mixed incontinence and did not specifically refer to stress incontinence. Tsai et al [34] assessed mainly 2 questionnaires including the Urge-Urinary Distress Inventory and the Overactive Bladder Questionnaire, making it difficult to analyze with other studies. Thus, these 2 articles were eventually excluded.
The limitations of the present study are listed as follows. First, its small sample size and insufficient statistical power. Second, the stimulation parameters and duration of the studies were not consistent, which makes us doubt whether meta-analysis can be carried out. However, the results based on RCTs were excellent despite inconsistent variables. Third, when analyzing on the data of Pad test, a hug heterogeneity that most likely caused by incomplete experimental design was recorded if we added the study by Manganotti et al [24] to the analysis. Thus, this study data was finally excluded by performing sensitivity analysis. Further well-designed RCTs for a long-term follow-up with a large sample size are needed.
Conclusion
In the short term, MS significantly improved the symptoms of SUI, reduced the number of leaks/3days and the daily loss of urine, with lower ICIQ scores and improved QoL scores. Although the beneficial effects of MS are temporary and not an alternative to surgical treatment, it can be considered as a conservative and noninvasive treatment approach in the management of SUI in patients either ineligible for or unwilling to undergo surgery. 
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